DT
PBYI icon

Diversified Trust’s Puma Biotechnology PBYI Stock Holding History

Diversified Trust’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,175
Closed -$48K – 840
2022
Q3 		$48K Hold
20,175
– – ﹤0.01% 749
2022
Q2 		$57K Sell
20,175
-5,461
-21% -$13.6K ﹤0.01% 729
2022
Q1 		$74K Sell
25,636
-52
-0.2% -$135 ﹤0.01% 783
2021
Q4 		$78K Buy
25,688
+6,053
+31% +$26.3K ﹤0.01% 814
2021
Q3 		$138K Sell
19,635
-7,235
-27% -$54.2K 0.01% 752
2021
Q2 		$247K Buy
26,870
+15,218
+131% +$154K 0.01% 623
2021
Q1 		$113K Sell
11,652
-2,065
-15% -$23.1K ﹤0.01% 726
2020
Q4 		$141K Buy
+13,717
New +$139K 0.01% 694

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Diversified Trust's PBYI Position: Q4 2022 in Review

Diversified Trust sold out of Puma Biotechnology (PBYI) in Q4 2022, closing a stake of 20,175 shares — an estimated $48K sold.

Diversified Trust first reported a position in PBYI in Q4 2020 and held it in 8 quarters. The position peaked at $247K in Q2 2021. 88 funds tracked by Wall St. Rank hold PBYI as of Q4 2022.

  • Diversified Trust reported no remaining Puma Biotechnology position as of Q4 2022 after selling out during the quarter.
  • Diversified Trust sold 20,175 Puma Biotechnology shares in Q4 2022, an estimated $48K.
  • Diversified Trust first reported a position in Puma Biotechnology in Q4 2020 and held it in 8 quarters.
  • Diversified Trust's Puma Biotechnology position peaked at $247K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2022.

Based on Diversified Trust's 13F filing for Q4 2022, filed 17 Jan 2023.